Report of activities carried out by the National Anti-Doping Committee (CNA/MEX-NADO) during 2021 / Comité Nacional Antidopaje de México (CNA/MEX-NADO). - Mexico City : CNA/MEX-NADO, 2022

Report Attività Antidoping NADO Italia Anno 2021  / Organizzazione Nazionale Antidoping (NADO Italia). - Roma : NADO Italia, 2022

Independent Observers Report of the Olympic Games, Tokyo 2020 / Francesca Rossi. - Independent Observer Team. - Montreal : World Anti-Doping Agency (WADA), 2021

2020 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2021

Contents:

• Executive Summary - pp. 2-9 (7 pages)
• Laboratory Report -– pp. 10-36 (27 pages)
• Sport Report - pp. 37-137 (101 pages)
• Testing Authority Report - pp. 138-244 (107 pages)
• ABP Report-Blood Analysis - pp. 245-279 (35 pages)

Report Highlights:

• A 46% decrease in the overall number of samples analyzed: 278,047 in 2019 to 149,758 in 2020.
• A decrease in the total percentage of Adverse Analytical Findings (AAFs): 0.97% in 2019 (2,702 AAFs from 278,047 samples) to 0.67% in 2020 (1,009 AAFs from 149,758 samples).
• All WADA-accredited Laboratories saw a decrease in the total number of samples recorded.
• A decrease in the total number and percentage of non-Athlete Biological Passport (ABP) blood samples analyzed: 9.1% in 2019 (25,339 of 278,047) and 7.3% (10,940 of 149,758) in 2020.
• A decrease of 38% in the number of ABP blood samples tested: 36,401 in 2019 to 22,666 in 2020.

The World Anti-Doping Agency (WADA) has publishes its 2020 Testing Figures Report (2020 Report), which summarizes the results of all the samples WADA-accredited Laboratories analyzed and reported in WADA’s Anti-Doping Administration and Management System (ADAMS) in 2020.

This is the sixth and last set of global testing figures under the 2015 World Anti-Doping Code (Code) that came into effect in January 2015. The 2020 Report – which includes an Executive Summary and sub-reports by Laboratory, Sport, Testing Authority and Athlete Biological Passport (ABP) Blood Analysis – includes in- and out-of-competition urine samples; blood and ABP blood data; and, the resulting Adverse Analytical Findings (AAFs) and Atypical Findings (ATFs).

2019 Anti-Doping Rule Violations (ADRVs) Report / World Anti-Doping Agency (WADA). - Montreal : WADA, 2021. - Report compiled based on decisions received by WADA before 31 January 2021

• The Report highlights 1,914 confirmed Anti-Doping Rule Violations in 2019, involving individuals from 117 nationalities and across 89 sports
• 1,537 ADRVs came from Adverse Analytical Findings and 377 from non-analytical, evidence-based intelligence

The World Anti-Doping Agency (WADA) has published its seventh annual Anti-Doping Rule Violations (ADRVs) Report, which is the official set of such figures under the World Anti-Doping Code. As usual, the Report is available in a PDF version as well as a dynamic, Excel version that illustrates the ADRV results in an interactive fashion.

The Report illustrates doping offences committed in global sport during 2019. It includes all decisions received by WADA’s Legal Affairs Department up to 31 January 2021. It highlights that there were a total of 1,914 ADRVs recorded in 2019. This represents a slight decrease relative to the 2018 figure of 1,923.

1,537 of the ADRVs came out of Adverse Analytical Findings (AAFs), commonly known as ‘positive’ results. The remainder were derived from investigations and evidence-based intelligence into 377 violations committed by athletes and athlete support personnel.

The 2019 Anti-Doping Rule Violations Report contains all ADRV decisions reported to WADA by Anti-Doping Organizations (ADOs). These decisions include those from AAFs reported in samples collected by ADOs in 2019 as well as from non-analytical ADRV decisions rendered in 2019.

As with previous years, the beginning of the report comprises explanations and definitions, an introduction and an executive summary highlighting key data. The first and second sections present the Results Management outcomes (including ADRVs) of all AAFs detected by WADA-accredited Laboratories for samples collected in 2019 from athletes in- and out-of-competition. They are presented by sport category (Section 1) and testing authority category (Section 2).

Section 3 includes ADRVs that resulted from non-analytical findings committed by athletes (presented by sport and nationality) and by athlete support personnel (presented by nationality).

Section 4 indicates the total number of ADRVs in 2019, which includes AAFs that resulted in an ADRV plus all non-analytical ADRVs. It presents the data by sport and nationality and is further broken down into type of samples (urine or blood), type of test (in- or out-of-competition) and athlete sex classification.
 

World Anti-Doping Agency 2020 annual report / World Anti-Doping Agency (WADA). - Montreal : WADA, 2021

CONTENTS

• Message From The President And The Director General
• Tributes To Richard Pound And John Fahey
• WADA's 2020-2024 Strategic Plan
• Governance
• 2020 Executive Committee
• 2020 Foundation Board
• 2020 Management Team
• Organizational Overview
• The World Anti-Doping Program
• Our Partners
• Capacity Building And NADO/RADO Relations
• Athlete Engagement
• Code Compliance
• Education
• Intelligence And Investigations
• Legal Affairs
• Science And Medicine
• Testing
• Information And Data Management
• 2020 Finance Overview
• 2020 Financial Statements

Sport Integrity Australia Annual Report 2020-2021 / Sports Integrity Australia. - Canberra, 2021

Contents:

• Chapter 1 - Ceo Message
• Chapter 2 - Overview
• Chapter 3 - Feature Articles
• Chapter 4 - Key Projects
• Chapter 5 - Advisory Council
• Chapter 6 - Australian Sports Drug Medical Advisory Committee
• Chapter 7 - Annual Performance Statement
• Chapter 8 - Management And Accountability
• Chapter 9 - Financial Statements
• Chapter 10 - Appendixes, Abbreviations And Glossary
• Chapter 11 - Indexes

Annual Report 2020-2021 / South African Institute for Drugfree Sport (SAIDS). - Cape Town : SAIDS, 2021

• ISBN: 978-0-621-49694-9